Skip to main content
. Author manuscript; available in PMC: 2018 Oct 25.
Published in final edited form as: Dev Psychopathol. 2017 May 2;29(4):1499–1511. doi: 10.1017/S0954579417000414

Table A.2.

Brain Derived Neurotrophic Factor (BDNF) in infancy and children’s developmental delay in the primary cohort (alternative cut-off)

Child Development
Exposure:
BDNF levels
Fine motor Gross motor Communication Personal-social Problem solving

OR (95%CI)
Random intercept
variability (SE)
BIC
OR (95%CI)
Random intercept
variability (SE)
BIC
OR (95%CI)
Random intercept
variability (SE)
BIC
OR (95%CI)
Random intercept
variability (SE)
BIC
OR (95%CI)
Random intercept
variability (SE)
BIC
Unadjusted 0.58 (0.33, 1.02)
7.16 (0.41)
7407.02
0.50 (0.27, 0.94)*
7.16 (0.44)
5055.32
0.45 (0.25, 0.82)*
8.17 (0.49)
6392.33
0.42 (0.24, 0.74)*
6.69 (0.41)
6066.81
0.53 (0.30, 0.95)*
7.51 (0.46)
6550.98
Adjusted 0.68 (0.38, 1.22)
7.05 (0.43)
7328.95
0.61 (0.33, 1.14)
7.21 (0.48)
5004.21
0.63 (0.33, 1.20)
8.32 (0.56)
6273.5
0.57 (0.33, 0.98)*
6.26 (0.40)
5978.04
0.67 (0.36, 1.23)
7.48 (0.49)
6457.89

BIC: Bayesian Information Criterion; OR: Odds Ratio; CI: Confidence Interval; SE: Standard Error

Primary cohort: singletons and one randomly selected twin of each pair

Developmental delay was assessed up to age 3 years using the Ages and Stages Questionnaires.

BDNF had a skewed distribution and therefore was log-transformed.

Models were adjusted for child gender, preterm birth, parity, infertility treatment, maternal age, race, education, history of smoking and drinking, pre-pregnancy body mass index, and having private insurance.

*

denotes P values <0.05